FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
The basis of allotment for Remus Pharmaceuticals IPO is available now.
To check Remus Pharmaceuticals IPO allotment status, follow the steps below:
On securing the allotment, you will receive the credit of equivalent shares in your Demat account.
If you have any concerns or queries about the allotment status, contact Link Intime India Private Ltd either by phone or email. Investors can call on +91-22-4918 6270 or send an email with all relevant details to remuspharmaceuticals.ipo@linkintime.co.in.
The Remus Pharmaceuticals IPO allotment status will be available on May 24, 2023, as per the timeline provided in the red-herring prospectus.
Below are the steps to check Remus Pharmaceuticals IPO allotment status online:
Note: The disabled button shows that the allotment is not yet available online.
The allotment result looks like as below:
The expected listing price of Remus Pharmaceuticals IPO depends on many factors including demand, nature of the business, market environment and state of the economy. The Remus Pharmaceuticals IPO grey market premium gives some hint but the actual listing price is difficult to guess.
Remus Pharmaceuticals IPO allotment status is expected on May 24, 2023. Click the green button Remus Pharmaceuticals IPO Allotment Status above to check the allotment. Note the button remains to disable until the allotment is available online.
If Remus Pharmaceuticals IPO oversubscribed in the retail category, the Remus Pharmaceuticals IPO shares will be distributed on a proportionate basis to Retail Individual Investors (RII). Each retail investor will get a minimum of 1 lot subject to the availability of shares in the retail portion. If enough shares are not available, a lottery is drawn to choose the investors.
The reason you didn't get the Remus Pharmaceuticals IPO could be:
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|